{"id":"https://openalex.org/W24388106","doi":null,"title":"Clinical applications of dosimetry for mIBG therapy.","display_name":"Clinical applications of dosimetry for mIBG therapy.","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W24388106","mag":"24388106","pmid":"https://pubmed.ncbi.nlm.nih.gov/21386786"},"language":"en","primary_location":{"id":"pmid:21386786","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21386786","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081540359","display_name":"Glenn Flux","orcid":"https://orcid.org/0000-0003-4743-2276","observed_orcids":["https://orcid.org/0000-0003-4743-2276"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G D Flux","raw_affiliation_strings":["Joint Department of Physics, Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, Surrey, UK. glenn.flux@icr.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joint Department of Physics, Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, Surrey, UK. glenn.flux@icr.ac.uk","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049536851","display_name":"Sarah J. Chittenden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S J Chittenden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044767725","display_name":"Frank H. Saran","orcid":"https://orcid.org/0000-0002-3448-5064","observed_orcids":["https://orcid.org/0000-0002-3448-5064"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Saran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064732539","display_name":"Mark N. Gaze","orcid":"https://orcid.org/0000-0002-8344-7902","observed_orcids":["https://orcid.org/0000-0002-8344-7902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M N Gaze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6433,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.67592519,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"55","issue":"2","first_page":"116","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.0210999995470047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metaiodobenzylguanidine","display_name":"metaiodobenzylguanidine","score":0.9750000238418579},{"id":"https://openalex.org/keywords/i-131-mibg","display_name":"I-131 MIBG","score":0.8529999852180481},{"id":"https://openalex.org/keywords/internal-dosimetry","display_name":"internal dosimetry","score":0.9210000038146973},{"id":"https://openalex.org/keywords/absorbed-dose","display_name":"absorbed dose","score":0.6729999780654907},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.8149999976158142},{"id":"https://openalex.org/keywords/norepinephrine-transporter","display_name":"norepinephrine transporter","score":0.8479999899864197},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9330000281333923},{"id":"https://openalex.org/keywords/weight-based-dosing","display_name":"weight-based dosing","score":0.5799999833106995},{"id":"https://openalex.org/keywords/individualized-treatment-planning","display_name":"personalized treatment planning","score":0.8579999804496765},{"id":"https://openalex.org/keywords/radiosensitizers","display_name":"radiosensitizers","score":0.8420000076293945},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C75088862","wikidata":"https://www.wikidata.org/wiki/Q2291081","display_name":"Dosimetry","level":2,"score":0.8693686723709106},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.8153835535049438},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7317991256713867},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5635756850242615},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4869926869869232},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.48591867089271545},{"id":"https://openalex.org/C201645570","wikidata":"https://www.wikidata.org/wiki/Q830637","display_name":"Radiation treatment planning","level":3,"score":0.4500371813774109},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.4291606843471527},{"id":"https://openalex.org/C151337348","wikidata":"https://www.wikidata.org/wiki/Q215313","display_name":"Absorbed dose","level":3,"score":0.4200228750705719},{"id":"https://openalex.org/C40993552","wikidata":"https://www.wikidata.org/wiki/Q514654","display_name":"Gold standard (test)","level":2,"score":0.4113900363445282},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.361444890499115},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27011364698410034}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011880","descriptor_name":"Radiotherapy Planning, Computer-Assisted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018358","descriptor_name":"Neuroendocrine Tumors","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D018358","descriptor_name":"Neuroendocrine Tumors","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019797","descriptor_name":"3-Iodobenzylguanidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019797","descriptor_name":"3-Iodobenzylguanidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:21386786","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21386786","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","raw_type":"Journal Article"},{"id":"mag:24388106","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21386786","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W1512455937","https://openalex.org/W1913993984"],"related_works":["https://openalex.org/W2795179419","https://openalex.org/W2010247282","https://openalex.org/W4200006612","https://openalex.org/W1974815949","https://openalex.org/W2183959707","https://openalex.org/W2034721431","https://openalex.org/W2083873064","https://openalex.org/W199947214","https://openalex.org/W2003352409","https://openalex.org/W2170229787"],"abstract_inverted_index":{"Metaiodobenzylguanidine":[0],"(mIBG),":[1],"developed":[2],"30":[3],"years":[4,38],"ago,":[5],"is":[6],"taken":[7],"up":[8],"by":[9,77,98],"tumours":[10,88],"expressing":[11],"the":[12,107,129],"noradrenaline":[13],"transporter.":[14],"Radiolabelled":[15],"with":[16,53],"I-123":[17],"or":[18],"I-131,":[19],"mIBG":[20,44,72],"has":[21,74],"become":[22],"a":[23,36,62,78],"gold":[24],"standard":[25,92],"for":[26,70],"diagnostic":[27],"imaging":[28],"of":[29,39,67,80,101,143],"pediatric":[30],"and":[31,89,93,111,116,141,145],"adult":[32],"neuroendocrine":[33],"cancer.":[34],"Within":[35],"few":[37],"its":[40],"clinical":[41],"introduction,":[42],"I-131":[43,71],"was":[45],"found":[46],"to":[47,87,125,128],"be":[48,126],"an":[49,99],"effective":[50],"palliative":[51],"treatment":[52,135],"minimal":[54],"toxicity":[55],"that":[56,83],"in":[57],"some":[58],"cases":[59],"could":[60],"produce":[61],"complete":[63],"response.":[64],"The":[65],"importance":[66],"internal":[68],"dosimetry":[69,140],"therapy":[73],"been":[75,114],"demonstrated":[76,115],"number":[79],"studies":[81,117],"showing":[82],"absorbed":[84,109],"doses":[85],"delivered":[86],"organs-at-risk":[90],"from":[91],"weight-based":[94],"activities":[95],"can":[96],"vary":[97],"order":[100],"magnitude.":[102],"However,":[103],"significant":[104],"correlations":[105],"between":[106],"whole-body":[108],"dose":[110],"myelotoxicity":[112],"have":[113,122],"based":[118,137],"on":[119,138],"this":[120],"relationship":[121],"enabled":[123],"treatments":[124],"tailored":[127],"individual.":[130],"Ongoing":[131],"developments":[132],"include":[133],"patient-specific":[134],"planning":[136],"tumour":[139],"cocktails":[142],"radionuclides":[144],"radiosensitisers.":[146]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}